BiotechTube
ClinBAY

ClinBAY

Zurich, Europe - Other· Est.
clinbay.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

ClinBAY is a specialized biometrics CRO offering statistical analysis, reporting, functional sourcing, and custom software development for clinical trials. With deep expertise spanning over 450 trials across 30 indications, the company positions itself as a strategic partner to accelerate drug development and regulatory approval. Its business model is purely service-based, leveraging proprietary software tools to enhance efficiency and quality for clients ranging from small biotechs to large pharma. The company is privately held and appears to be revenue-generating, with a seasoned management team leading its operations.

Digital Health

Technology Platform

Proprietary software tools (e.g., ClinXPORT, Decimaker) and custom development in SAS and R to automate clinical trial data analysis, reporting, and processing.

Opportunities

The growing complexity of clinical trials and the increase in virtual biotechs without internal stats teams drive demand for specialized, outsourced biometrics services.
Further development and licensing of proprietary software tools like ClinXPORT could create a scalable product revenue stream alongside service fees.

Risk Factors

High dependence on the R&D spending cycles of biopharma clients makes revenue susceptible to economic downturns.
Intense competition for both clients and specialized statistical talent poses a constant threat to market share and operational capacity.

Competitive Landscape

ClinBAY competes with large, full-service global CROs (e.g., IQVIA, Parexel) that offer biometrics as part of a broad suite and with numerous other boutique biometrics and statistical consulting firms. Its differentiation lies in its deep specialization, proprietary efficiency software, and flexible resourcing model.

More companies in Europe - Other →